193 related articles for article (PubMed ID: 28853721)
21. Insights into POT1 structural dynamics revealed by cryo-EM.
Smith EW; Lattmann S; Liu ZB; Ahsan B; Rhodes D
PLoS One; 2022; 17(2):e0264073. PubMed ID: 35176105
[TBL] [Abstract][Full Text] [Related]
22. TRF2 promotes dynamic and stepwise looping of POT1 bound telomeric overhang.
Paul T; Liou W; Cai X; Opresko PL; Myong S
Nucleic Acids Res; 2021 Dec; 49(21):12377-12393. PubMed ID: 34850123
[TBL] [Abstract][Full Text] [Related]
23. Dissecting Fission Yeast Shelterin Interactions via MICro-MS Links Disruption of Shelterin Bridge to Tumorigenesis.
Liu J; Yu C; Hu X; Kim JK; Bierma JC; Jun HI; Rychnovsky SD; Huang L; Qiao F
Cell Rep; 2015 Sep; 12(12):2169-80. PubMed ID: 26365187
[TBL] [Abstract][Full Text] [Related]
24. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
[TBL] [Abstract][Full Text] [Related]
25. In vivo stoichiometry of shelterin components.
Takai KK; Hooper S; Blackwood S; Gandhi R; de Lange T
J Biol Chem; 2010 Jan; 285(2):1457-67. PubMed ID: 19864690
[TBL] [Abstract][Full Text] [Related]
26. Fission yeast Pot1-Tpp1 protects telomeres and regulates telomere length.
Miyoshi T; Kanoh J; Saito M; Ishikawa F
Science; 2008 Jun; 320(5881):1341-4. PubMed ID: 18535244
[TBL] [Abstract][Full Text] [Related]
27. Distinct functions of POT1 at telomeres.
Barrientos KS; Kendellen MF; Freibaum BD; Armbruster BN; Etheridge KT; Counter CM
Mol Cell Biol; 2008 Sep; 28(17):5251-64. PubMed ID: 18519588
[TBL] [Abstract][Full Text] [Related]
28. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
[TBL] [Abstract][Full Text] [Related]
29. Functional diversity of human protection of telomeres 1 isoforms in telomere protection and cellular senescence.
Yang Q; Zhang R; Horikawa I; Fujita K; Afshar Y; Kokko A; Laiho P; Aaltonen LA; Harris CC
Cancer Res; 2007 Dec; 67(24):11677-86. PubMed ID: 18089797
[TBL] [Abstract][Full Text] [Related]
30. Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres.
Cantara S; Capuano S; Capezzone M; Benigni M; Pisu M; Marchisotta S; Pacini F
Thyroid; 2012 Apr; 22(4):363-8. PubMed ID: 22304389
[TBL] [Abstract][Full Text] [Related]
31. POT1 Regulates Proliferation and Confers Sexual Dimorphism in Glioma.
Jalali A; Yu K; Beechar V; Bosquez Huerta NA; Grichuk A; Mehra D; Lozzi B; Kong K; Scott KL; Rao G; Bainbridge MN; Bondy ML; Deneen B
Cancer Res; 2021 May; 81(10):2703-2713. PubMed ID: 33782098
[TBL] [Abstract][Full Text] [Related]
32. TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1.
Frescas D; de Lange T
Mol Cell Biol; 2014 Apr; 34(7):1349-62. PubMed ID: 24469404
[TBL] [Abstract][Full Text] [Related]
33. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Aoude LG; Pritchard AL; Robles-Espinoza CD; Wadt K; Harland M; Choi J; Gartside M; Quesada V; Johansson P; Palmer JM; Ramsay AJ; Zhang X; Jones K; Symmons J; Holland EA; Schmid H; Bonazzi V; Woods S; Dutton-Regester K; Stark MS; Snowden H; van Doorn R; Montgomery GW; Martin NG; Keane TM; López-Otín C; Gerdes AM; Olsson H; Ingvar C; Borg A; Gruis NA; Trent JM; Jönsson G; Bishop DT; Mann GJ; Newton-Bishop JA; Brown KM; Adams DJ; Hayward NK
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505254
[TBL] [Abstract][Full Text] [Related]
34. The POT1-TPP1 telomere complex is a telomerase processivity factor.
Wang F; Podell ER; Zaug AJ; Yang Y; Baciu P; Cech TR; Lei M
Nature; 2007 Feb; 445(7127):506-10. PubMed ID: 17237768
[TBL] [Abstract][Full Text] [Related]
35. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
[TBL] [Abstract][Full Text] [Related]
36. The OB-fold domain 1 of human POT1 recognizes both telomeric and non-telomeric DNA motifs.
Choi KH; Lakamp-Hawley AS; Kolar C; Yan Y; Borgstahl GEO; Ouellette MM
Biochimie; 2015 Aug; 115():17-27. PubMed ID: 25934589
[TBL] [Abstract][Full Text] [Related]
37. Germline mutations in shelterin complex genes are associated with familial glioma.
Bainbridge MN; Armstrong GN; Gramatges MM; Bertuch AA; Jhangiani SN; Doddapaneni H; Lewis L; Tombrello J; Tsavachidis S; Liu Y; Jalali A; Plon SE; Lau CC; Parsons DW; Claus EB; Barnholtz-Sloan J; Il'yasova D; Schildkraut J; Ali-Osman F; Sadetzki S; Johansen C; Houlston RS; Jenkins RB; Lachance D; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Walsh KM; Davis FG; Lai R; Shete S; Aldape K; Amos CI; Thompson PA; Muzny DM; Gibbs RA; Melin BS; Bondy ML;
J Natl Cancer Inst; 2015 Jan; 107(1):384. PubMed ID: 25482530
[TBL] [Abstract][Full Text] [Related]
38. Structural basis of human telomerase recruitment by TPP1-POT1.
Sekne Z; Ghanim GE; van Roon AM; Nguyen THD
Science; 2022 Mar; 375(6585):1173-1176. PubMed ID: 35201900
[TBL] [Abstract][Full Text] [Related]
39. Investigation of conformational dynamics of Tyr89Cys mutation in protection of telomeres 1 gene associated with familial melanoma.
Amir M; Ahamad S; Mohammad T; Jairajpuri DS; Hasan GM; Dohare R; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2021 Jan; 39(1):35-44. PubMed ID: 31847782
[TBL] [Abstract][Full Text] [Related]
40. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
Richard MA; Lupo PJ; Morton LM; Yasui YA; Sapkota YA; Arnold MA; Aubert G; Neglia JP; Turcotte LM; Leisenring WM; Sampson JN; Chanock SJ; Hudson MM; Armstrong GT; Robison LL; Bhatia S; Gramatges MM
PLoS One; 2020; 15(2):e0228887. PubMed ID: 32040538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
